Author: Haritha Karyampudi
Hydrogel Implant: A New Hope for Women’s Health
Researchers created biocompatible, stimuli-responsive hydrogel implants for reversible fallopian tube occlusion, which can be used.
Hormone Therapy & Breast Cancer: Alzheimer’s Risk?
Researchers examined the relationship between hormone-modulating therapy (HMT) for treating breast cancer and women 65.
Flu Virus Uses Second Pathway to Infect Cells
The majority of influenza viruses enter animal or human cells through particular surface-based routes. It.
Neutrophil-Engineered Nanovesicles: A Breakthrough in Wound Care
Nanovesicles (NVs) have been created from activated neutrophils in a recent study, demonstrating their potential.
Active Commuters Have Lower Heart Disease & Cancer Risk
In a recent study that was published in the BMJ Public Health, researchers looked at.
Semaglutide Shows No Higher Neuropsychiatric Risk
A group of researchers used a propensity-score matched cohort to assess the 12-month neurological and.
Genetic Marker Predicts Gabapentin Response in Chronic Pelvic Pain
According to studies, women who have a certain type of the pain gene are more.
Triad of Immune Cells Boosts Cancer Immunotherapy Success
One annoying aspect of modern cancer immunotherapy is this. While they can occasionally totally eradicate.
One-Time Prime Editing for Cystic Fibrosis
Researchers optimized prime editing (PE) for the effective correction of the cystic fibrosis (CF) transmembrane.
New Guidance on Muscle-Building Supplements for Teens
According to a commentary in the Journal of Adolescent Health, there is widespread use of.